SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007157
Filing Date
2021-05-14
Accepted
2021-05-14 07:04:46
Documents
45
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plx-20210331x10q.htm   iXBRL 10-Q 1016699
2 EX-10.1 plx-20210331xex10d1.htm EX-10.1 121899
3 EX-10.2 plx-20210331xex10d2.htm EX-10.2 541019
4 EX-10.3 plx-20210331xex10d3.htm EX-10.3 30422
5 EX-31.1 plx-20210331xex31d1.htm EX-31.1 10027
6 EX-31.2 plx-20210331xex31d2.htm EX-31.2 10387
7 EX-32.1 plx-20210331xex32d1.htm EX-32.1 6088
8 EX-32.2 plx-20210331xex32d2.htm EX-32.2 6114
9 GRAPHIC plx-20210331x10q005.jpg GRAPHIC 62538
10 GRAPHIC plx-20210331x10q006.jpg GRAPHIC 66284
11 GRAPHIC plx-20210331x10q007.jpg GRAPHIC 33213
  Complete submission text file 0001558370-21-007157.txt   4204275

Data Files

Seq Description Document Type Size
12 EX-101.SCH plx-20210331.xsd EX-101.SCH 24380
13 EX-101.CAL plx-20210331_cal.xml EX-101.CAL 34415
14 EX-101.DEF plx-20210331_def.xml EX-101.DEF 78300
15 EX-101.LAB plx-20210331_lab.xml EX-101.LAB 189287
16 EX-101.PRE plx-20210331_pre.xml EX-101.PRE 162545
17 EXTRACTED XBRL INSTANCE DOCUMENT plx-20210331x10q_htm.xml XML 277815
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 21921912
SIC: 2836 Biological Products, (No Diagnostic Substances)